Research challenges in adolescent and young adult cancer survivor research

Authors

  • Emily S. Tonorezos MD, MPH,

    1. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
    Search for more papers by this author
  • Kevin C. Oeffinger MD

    Corresponding author
    1. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York
    2. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065
    Search for more papers by this author
    • Fax: (646) 888-4923


  • The articles in this supplement represent presentations and discussions at the “International Workshop on Adolescents and Young Adults with Cancer: Towards Better Outcomes in Canada” that was held in Toronto, Ontario, March 11-13, 2010.

  • Workshop on Adolescents and Young Adults with Cancer: Towards Better Outcomes in Canada, Supplement to Cancer.

Abstract

Every year in Canada and the United States, about 26,000 adolescent and young adults (AYA) between ages 15 and 29 years are diagnosed with cancer. Although the majority of AYA cancer patients will survive their primary cancer, many will develop serious health problems or die prematurely secondary to their curative cancer therapy. Much is known about the long-term health outcomes after adolescent cancer. In contrast, there remain substantial gaps in our understanding of the long-term outcomes after most young adult cancers. To optimize the health and quality of life of AYA cancer survivors and improve upon curative cancer therapy, it is essential to further investigate the long-term outcomes of this population. Before embarking upon this endeavor, it is important for the investigator and the funding agency to be cognizant about some of the unique challenges in research of AYA cancer survivors. To this end, the authors present a brief overview of some of the key research challenges, discuss the strengths and limitations of using available AYA cohorts and databases, and highlight potential future directions. Cancer 2011;117(10 suppl):2295–300. © 2011 American Cancer Society.

Ancillary